| Health / Medical Topics |
Dipeptidyl Peptidase-4 Inhibitor
Any inhibitor of the proline-specific serine protease dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. DPP-4 inhibitors bind to DPP-4 and inhibit the breakdown of the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). This prolongs incretin activity, increases postprandial insulin release, decreases glucagon release, delays gastric emptying and lowers blood glucose levels. The risk for hypoglycemia is negligible with the use of DPP-4 inhibitors. (NCI Thesaurus)
YOU MAY ALSO LIKE
The determination of the amount of the biological activity of dipeptidyl peptidase-4 in a sample.
Dipeptidyl peptidase 4 (766 aa, ~88 kDa) is encoded by the human DPP4 gene. This protein is involved in proteolytic regulation of…
Any of the toxic or carcinogenic chlorinated hydrocarbons that occur as impurities in herbicides.
A beta-2 -adrenergic agonist with bronchodilator activity. Dioxifedrine selectively binds to and activates beta-2 adrenergic receptors in bronchiolar smooth muscle, thereby causing…
An herbal remedy derived from the dried root of Dioscorea villosa, a perennial vine native to North America, Mexico and Asia. The…
A unit of measurement of the optical power of a curved mirror or lens represented by the inverse of the focal length…
